Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,645.99
(
0.18%
)
News Focus
News Focus

Replies to post #17680 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #17680 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

alternatepatel

09/29/17 3:38 AM

#17681 RE: DewDiligence #17680

It appears that Amgen didn't try to circumvent Humira formulation patents.
Amjevita chemistry review suggests that it clearly falls within scope of Humira formulation patents.

9114166
9085619